the current standard of care for mds-related cytopenias and how treatment strategies may evolve
Published 1 year ago • 50 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:20
the current standard of care for patients with lower-risk mds
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
4:08
personalization of care for mds patients
-
2:16
current and future treatment approaches for hr-mds
-
4:28
current and emerging treatment options for mds
-
1:26
current and emerging prognostic factors for mds/mpn
-
1:16
state of the art: mds
-
3:54
life with mds: jill shares how her family helped her overcome an mds diagnosis
-
7:54
patient/caregiver stories - living with mds
-
6:45
mds survivor: cindy sargeant
-
3:38
a new set of treatment options for low-risk mds
-
2:04
state-of-the-art treatment for hr-mds
-
1:02
the changing standard of care in dlbcl
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
2:43
novel therapies in the future of mds treatment
-
1:02
emerging treatment options for lower- and higher-risk mds and ongoing trials
-
1:04
the future of mds management
-
3:31
promising treatment options emerging for higher-risk mds & the value of clinical trials
-
1:30
the prognostic value of patient-reported outcomes in mds
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data